The structural basis of protein folding and its links with human disease

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 356, Issue 1406, 2001, Pages 133-145

  Dobson, C M ^a   Swoboda, B E P ^a   Joniau, M ^a   Weissman, C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ageing; Aggregation; Amyloid fibrils; Energy landscapes; Folding diseases; Folding mechanisms

Indexed keywords

EID: 0035961329     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2000.0758     Document Type: Conference Paper

References (66)

1. Principles that govern the folding of protein chains
2. A surprising simplicity to protein folding
3. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
4. Funnels, pathways and the energy landscape of protein folding: A synthesis
5. Fast events in protein folding
6. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease related variants
7. The ultrastructural organisation of amyloid fibrils by atomic force microscopy
8. Mutational analysis of acylphosphatase suggests the importance of topology and contact order in protein folding
9. Designing conditions for in vitro formation of amyloid protofilaments and fibrils
10. Mutational analysis of the propensity for amyloid formation by a globular protein
11. From Levinthal to pathways to funnels
12. Understanding protein folding via free energy surfaces from theory and experiment
13. Protein misfolding, evolution and disease
14. How do we explore the energy landscape for folding?
15. Protein folding
16. Kinetic studies of protein folding using NMR spectroscopy
17. The fundamentals of protein folding: Bringing together theory and experiment
18. Understanding protein folding - The lysozyme story so far
19. Protein folding: A perspective from theory and experiment
20. The role of assembly in insulin's biosynthesis
21. Equilibrium NMR studies of unfolded and partially folded proteins
22. Principles of protein folding in the cellular environment
23. Probing the structure of folding intermediates
24. Nucleation mechanisms in protein folding
25. Protein folding in the cell
26. Amyloid fibril formation by an SH3 domain
27. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
28. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing
29. The Levinthal paradox: Yesterday and today
30. The alternative conformations of amyloid proteins and their multi-step assembly pathways
31. Rational design of potent human transthyretin amyloid disease inhibitors
32. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the β-domain
33. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
34. Mad cows meet psi-chotic yeast: The expansion of the prion hypothesis
35. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module
36. Physical properties of cytoplasm
37. Chemical dissection and reassembly of amyloid fibrils formed by a peptide fragment of transthyretin
38. Formation of mixed fibrils reveals the generic nature and potential application of protein amyloid structures
39. Mapping the transition-state and pathway of protein folding by protein engineering
40. Implications of macromolecular crowding for protein assembly
41. Independent nucleation and heterogeneous assembly of structure during folding of equine lysozyme
42. Amyloid fibril formation and seeding by wild type human lysozyme and its disease related mutational variants
43. Amyloid fibril formation by a helical cytochrome
44. Glutamine repeats and neuro-degenerative disease: Molecular aspects
45. Time-resolved biophysical methods in the study of protein folding
46. Contact order, transition state placement and the refolding rates of single domain proteins
47. Prion diseases and the BSE crisis
48. From computer simulations to human disease: Emerging themes in protein folding
49. The denatured state and its role in protein stability
50. The concept of a random coil. Residual structure in peptides and denatured proteins
51. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
52. Liver transplantation for non-Met30 TTR associated familial amyloid polyneuropathy
53. The structure of amyloid fibrils by electron microscopy and X-ray diffraction
54. Common core structure of amyloid fibrils by synchrotron X-ray diffractions
55. Amyloidosis
56. Deciphering the time-scales and mechanisms of protein folding using minimal off-lattice models
57. Defective protein folding as a basis of human disease
58. Protein engineering as a strategy to avoid formation of amyloid fibrils
59. Prions of yeast and fungi - Proteins as genetic material
60. Chaperone substrates inside the cell
61. Molecular crowding: Analysis of effects of high concentrations of inert cosolutes on biochemical equilibria and rates in terms of volume exclusion